» Articles » PMID: 26948457

Application of Sepsis Calculator in Newborns with Suspected Infection

Overview
Publisher Informa Healthcare
Date 2016 Mar 8
PMID 26948457
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To compare actual antibiotic use to the stratification based on the sepsis calculator in newborns with suspected early onset sepsis (EOS). To investigate differences in EOS risk and vital signs between newborns that received early (<12 h) versus late antibiotics (≥12 h of life).

Methods: Newborns born ≥34 weeks gestation in 2014 treated with antibiotics started within 72 h after birth were included. We calculated the risk per 1000 live births and retrospectively assigned each newborn to one of four recommended categories using the sepsis calculator.

Results: There were 2094 newborns, 111 (5.3%) received antibiotics and 108 newborns were included. The incidence of culture-proven EOS was 0.096%. In 57 newborns, the advice of the sepsis calculator was not to start antibiotic therapy. Antibiotic treatment was started early in 66 (61%) and late in 42 (39%) newborns. In the "late treatment" group, clinical condition deteriorated, including two newborns with culture-proven EOS. Tachypnea and respiratory distress were significantly more present.

Conclusion: Antibiotic use could be reduced by more than 50%. Newborns with initial low sepsis risk score clinically deteriorated beyond 12 h of life. Continuous good clinical observation remains very important. Prospective validation is necessary to evaluate the safety of this approach.

Citing Articles

Predicting community acquired bloodstream infection in infants using full blood count parameters and C-reactive protein; a machine learning study.

Brouwer L, Cunney R, Drew R Eur J Pediatr. 2024; 183(7):2983-2993.

PMID: 38634890 PMC: 11192659. DOI: 10.1007/s00431-024-05441-6.


Screening for early-onset neonatal sepsis on the Kaiser Permanente sepsis risk calculator could reduce neonatal antibiotic usage by two-thirds.

Fernandes M, Winckworth L, Lee L, Akram M, Struthers S Pediatr Investig. 2022; 6(3):171-178.

PMID: 36203516 PMC: 9523803. DOI: 10.1002/ped4.12344.


Effect of antibiotics in the first week of life on faecal microbiota development.

Van Daele E, Kamphorst K, Vlieger A, Hermes G, Milani C, Ventura M Arch Dis Child Fetal Neonatal Ed. 2022; .

PMID: 35534183 PMC: 9606546. DOI: 10.1136/archdischild-2021-322861.


Effects of early-life antibiotics on the developing infant gut microbiome and resistome: a randomized trial.

Reyman M, van Houten M, Watson R, Chu M, Arp K, de Waal W Nat Commun. 2022; 13(1):893.

PMID: 35173154 PMC: 8850541. DOI: 10.1038/s41467-022-28525-z.


Neonatal early-onset infections: Comparing the sensitivity of the neonatal early-onset sepsis calculator to the Dutch and the updated NICE guidelines in an observational cohort of culture-positive cases.

Snoek L, van Kassel M, Krommenhoek J, Achten N, Plotz F, Van Sorge N EClinicalMedicine. 2022; 44:101270.

PMID: 35059618 PMC: 8760457. DOI: 10.1016/j.eclinm.2021.101270.